https://www.selleckchem.com/products/VX-809.html
Serum alpha-fetoprotein (AFP) is the approved serum marker for hepatocellular carcinoma (HCC) screening. However, not all HCC patients show high (≥ 20ng/mL) serum AFP, and the molecular mechanisms of HCCs with normal ( 20ng/mL) serum AFP remain to be elucidated. Therefore, we aimed to identify biological features of HCCs with normal serum AFP by investigating differential alternative splicing (AS) between HCCs with normal and high serum AFP. We performed a genome-wide survey of AS events in 249 HCCs with normal (n = 131) and high (n
Like
Comment
Share
